Ocean Bio-Chem (NASDAQ:OBCI) changed -4.51% to recent value of $3.39. The stock transacted 111589 shares during most recent day however it has an average volume of 11.31K shares. It spotted trading -27.99% off 52-week high price. On the other end, the stock has been noted 16.90% away from the low price over the last 52-weeks.
On Aug. 14, 2019, Ocean Bio-Chem (NASDAQ:OBCI) released its financial results for the second quarter and first six months of 2019.
For the second quarter of 2019, net sales were approximately $10.9 million, compared to net sales of approximately $11.4 million in the second quarter of 2018. The Company believes the adverse severe weather conditions during the second quarter, in some regions of the United States effected sales results. Second quarter 2019 net income was approximately $1.0 million compared to net income of approximately $1.1 million for the second quarter of 2018. Second quarter net income per share was approximately $0.11 per share as compared to net income per share of $0.12 in the second quarter of 2018.
Net sales for the six months ended June 30, 2019 were approximately $20.0 million, an increase of approximately 1% compared to net sales of approximately $19.8 million for the first six months of 2018. This was a six months record sales for the Company. Net income for the first six months of 2019 was also a Company record of approximately $1.7 million, a 5% increase compared to net income of approximately $1.6 million for the first six months of 2018. Net income per common share was $0.18 for the first six months of both 2019 and 2018.
OBCI has a gross margin of 34.90% and an operating margin of 9.40% while its profit margin remained 7.00% for the last 12 months. Its earnings per share (EPS) expected to touch remained 10.50% for this year.
The company has 9.36M of outstanding shares and 3.58M shares were floated in the market. According to the most recent quarter its current ratio was 6.2 that represents company’s ability to meet its current financial obligations. The price moved ahead of -5.43% from the mean of 20 days, -1.89% from mean of 50 days SMA and performed -1.54% from mean of 200 days price. Company’s performance for the week was -3.42%, -5.57% for month and YTD performance remained 4.95%.
Sarah Gleason is a self-taught investor and follows the value investing approach to picking stocks. She possesses over 10 years of investment experience, an M.B.A, and is also certified in Risk Management Assurance. Sarah is a Certified Internal Auditor, Data Miner, and author with a career broadly spanning over multiple business areas. She has exploited those observations and developed investment tactics within a fundamentally sound long-term investment strategy. She covers Earnings News category for our site.
Address: 271 Garfield Road, Forest City, Illinois
Phone number: 309-597-0351